Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein

Journal of Lipid Research

Volumn 40, Issue 3, 1999, Pages 543-555

  Bondarenko, Pavel V ^a,b   Cockrill, Steven L ^a   Watkins, Layle K ^a   Cruzado, Ingrid D ^a   Macfarlane, Ronald D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Thermo BioAnalysis Corporation   (United States)

Author keywords

ApoE; C apolipoproteins; C18 solid phase extraction; Molecular weight; Oxidized apolipoproteins; Proteolytic events; Quantitative polymorphism; Truncated apolipoproteins

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; ISOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ACCURACY; ADULT; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN ISOLATION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS; SOLID PHASE EXTRACTION;

ADULT; AMINO ACID SEQUENCE; APOLIPOPROTEIN C-I; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CARBOHYDRATE SEQUENCE; CENTRIFUGATION, DENSITY GRADIENT; GLYCOSYLATION; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, VLDL; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; OXIDATION-REDUCTION; PHENOTYPE; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0033014724     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Kinnunen, P. K., R. L. Lackson, L. C. Smith, A. M. Gotto, Jr., and J. T. Sparrow. 1977. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc. Natl. Acad. Sci. USA. 74: 4848-4851.
2. Wang, C. S., W. J. McConathy, H. U. Kloer, and P. Alaupovic. 1985. Moditaion of lipoprotein lipase aclivity by apolipoproteins. Effects of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.
3. Mahley, R. W., T. L. Innerarity, S. C. Rall, Jr., and K. H. Weisgraber. 1984. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25: 1277-1292.
4. Swaney, J. B., and K. H. Weisgraber. 1994. Effect of apolipoprotein C-I on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J. Lipid Res. 35: 134-142.
5. Poensgen, J. 1990. Apolipoprotein C-I inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes. Biochim. Biophys. Acta. 1042: 188-192.
6. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
7. Dominiczak, M. H. 1997. Apolipoproteins and lipoproteins in human plasma. In Handbook of Lipoprotein Testing. N. Rifai, G. R. Warnick, and M. H. Dominiczak, editors. AACC Press, Washington, DC. 1-24.
8. Sirtori, C. R., G. Franceschini, H. B. Brewer, Jr., and G. Assmann. 1988. Human Apolipoprotein Mutants 2: From Genes Structure to Phenotypic Expressions. Plenum Press, New York and London.
9. Fojo, S. S., and H. B. Brewer, Jr. 1992. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J. Intern. Med. 231: 669-677.
10. Reina, M., J. D. Brunzell, and S. S. Deeb. 1992. Molecular basis of familial chylomicronemia: mutation in the lipoprotein lipase and apolipoprotein C-II gene. J. Lipid Res. 33: 1823-1832.
11. Scanu, A. M., R. E. Byrne, and C. Edelstein. 1984. Proteolytic events affecting plasma apolipoptroteins at the co- and post-translational levels and after maturation. J. Lipid Res. 25: 1593-1601.
12. Hussain, M. M., and V. I. Zannis. 1990. Intracellular modification of human apolipoprotein AII (apo AII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins. Biochemistry. 29: 209-217.
13. Jackson, R. L., J. T. Sparrow, H. N. Baker, J. D. Morrisett, O. D. Taunton, and A. M. Gotto, Jr. 1974. The primary structure of apolipoprotein-serine. J. Biol. Chem. 249: 5308-5313.
14. Shulman, R. S., P. N. Herbert, K. Wehrly, and D. S. Fredrickson. 1975. The complete amino acid sequence of C-I (ApoLp-Ser), an apolipoprotein from human very low density lipoproteins. J. Biol. Chem. 250: 182-190.
15. Hospattankar, A. V., T. Fairwell, R. Ronan, and H. B. Brewer, Jr. 1984. Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J. Biol. Chem. 259: 318-322.
16. Hospattankar, A. V., H. B. Brewer, Jr., R. Ronan, and T. Fairwell. 1986. Amino acid sequence of human plasma polipoprotein C-III from normolipidemic subjects. FEBS Lett. 197: 67-73.
17. McLean, J. W., N. A. Elshourbady, D. J. Chang, R. W. Mahley, and J. M. Taylor. 1984. Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J. Biol. Chem. 259: 6498-6504.
18. Rall, S. C., Jr., K. H. Weisgraber, and R. W. Mahley. 1982. Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257: 4171-4178.
19. Utermann, G., Langenbeck, U. Beisiegel, and W. Weber. 1980. Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet. 32: 339-347.
20. Utermann, G., I. Kindermann, H. Kaffarnik, and A. Steinmetz. 1982. Apolipoprotein E phenotypes and hyperlipidemia. Hum. Genet. 60: 232-236.
21. Zannis, V. I., and J. I., Breslow. 1981. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry. 20: 1033-1041.
22. de Knijff, P., A. M. J. M. van den Maagdenberg, R. R. Frants, and L. M. Havekes. 1994. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum. Mutat. 4: 178-194.
23. Zannis, V. I., J. McPherson, G. Goldberger, S. K. Karathanasis, and J. L. Breslow. 1984. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J. Biol. Chem. 259: 5495-5499.
24. Haase, R., I. Menke-Mollers, and K. Oette. 1988. Analysis of human apolipoproteins C by isoelectric focusing in immobilized pH gradients. Electrophoresis. 9: 569-575.
25. Sharpe, C. R., A. Sidoli, C. S. Shelley, M. A. Lucero, C. C. Shoulder, and F. E. Baralle. 1984. Human apolipoproteins AI, AII, CII and CIII. cDNA sequence and mRNA abundance. Nucleic Acids Res. 12: 3917-3932.
26. Fojo, S. S., L. Taam, T. Fairwell, R. Ronan, C. Bishop, M. S. Meng, J. M. Hoeg, D. L. Sprecher, and H. B. Brewer, Jr. 1986. Human preproapolipoprotein C-II. Analysis of major plasma isoforms. J. Biol. Chem. 261: 9591-9594.
27. Brown, W. V., R. I. Levy, and D. S. Fredrickson. 1970. Further characterization of apolipoproteins from human plasma very low density lipoproteins. J. Biol. Chem. 245: 6588-6594.
28. Albers, J. J., and A. M. Scanu. 1971. Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins. Biochim. Biophys. Acta. 236: 29-37.
29. Brewer, H. B., Jr., R. S. Shulman, P. N. Herbert, R. Ronan, and K. Wehrly. 1974. The complete amino acid sequence of alanine apolipoprotein (apo C-III), an apolipoprotein from human plasma very low density lipoproteins. J. Biol. Chem. 249: 4975-4984.
30. Jabs, H-U. and G. Assmann. 1987. Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry. J. Chromatogr. 414: 323-333.
31. 0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure. J. Lipid Res. 30: 1781-1787.
32. Atger, V., F. Duval, K. Frommherz, T. Drucke, and B. Lacour. 1988. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I. Atherosclerosis. 74: 75-83.
33. 2. Lancet. 8144: 667-671.
34. Edelstein, C., and A. M. Scanu. 1986. Precautionary measures for collecting blood destined for lipoprotein isolation. Methods Enzymol. 128: 151-155.
35. Schumaker, V., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
36. Saruta, H., Y. Ashihara, M. Sugiyama, M. Roth, E. Miyagawa, Y. Kido, and Y. Kasahara. 1986. Colorimetric determination of carboxypeptidase A activity in serum. Clin. Chem. 32: 748-751.
37. von Eckardstein, A., M. Walter, H. Holz, A. Benninghoven, G. Assmann, A. Roetrige, and R. Kock. 1991. Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III. J. Lipid Res. 32: 1465-1476.
38. Hughes, T. A., M. A. Moore, P. Neame, M. F. Medley, and B. H. Chung. 1988. Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high performance liquid chromatography. J. Lipid Res. 29: 363-376.
39. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jurgens. 1998. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13: 341-390.
40. Nagano, Y., H. Arai, and T. Kita. 1991. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA. 88: 6457-6461.
41. O'Farrell, P. 1975. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250: 4007-4021.
42. Sprecher, D. L., L. Taam, and H. B. Brewer, Jr. 1984. Two-dimensional electrophoresis of human plasma apolipoproteins. Clin. Chem. 30: 2084-2092.
43. Schmitz, G., K. Ilsemann, B. Melnik, and G. Assmann. 1983. Isoproteins of human apolipoprotein A-II: isolation and characterization. J. Lipid Res. 24: 1021-1029.
44. Torgerson, D. F., R. P. Skowronski, and R. D. Macfarlane. 1974. New approach Io the mass spectrometry of non-volatile compounds. Biochem. Biophys. Res. Commun. 60: 616-621.
45. Hillenkamp, F., M. Karas, R. C. Beavis, and B. T. Chait. 1991. Matrix-assisted lazer desorption/ionization mass spectrometry of biopolymers. Anal. Chem. 63: 1193A-1202A.
46. Fenn, J. B., M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science. 246: 64-71.
47. Beavis, R. C., and B. T. Chait. 1990. Rapid, sensitive analysis of protein mixtures by mass spectrometry. Proc. Natl. Acad. Sci. USA. 87: 6873-6877.
48. Jabs, H-U., G. Assmann, D. Greifendorf, and A. Benninghoven. 1986. High performance liquid chromatography and time-of-flight secondary ion mass spectrometry: a new dimension in structural analysis of apolipoproteins. J. Lipid Res. 27: 613-621.
49. Weinmann, W., C. E. Parker, L. J. Deterding, D. I. Papac, J. Hoyes, M. Przybylski, and K. B. Tomer. 1994. Capillary electrophoresis-matrix-assisted laser-desorption ionization mass spectrometry of proteins. J. Chromatogr. A. 680: 353-361.
50. Wang, C. S., D. Downs, A. Dashti, and K. W. Jackson. 1996. Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli. Biochim. Biophys. Acta. 1302: 224-230.
51. Smith, R. D., C. J. Barinaga, and H. R. Udseth. 1989. Tandem mass spectrometry of highly charged cytohrome c molecular ions produced by electrospray ionization. J. Phys. Chem. 93: 5019-5022.
52. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
53. Osborne, J. C. 1986. Delipidation of plasma lipoproteins. Methods Enzymol. 128: 213-222.
54. Cruzado, I. D., S. Song, S. F. Crouse, B. C. O'Brien, and R. D. Macfarlane. 1996. Characterization and quantitation of the apoproteins of high-density lipoprotein by capillary electrophoresis. Anal. Biochem. 243: 100-109.
55. Bondarenko, P. V., and R. D. Macfarlane. 1997. A new electrospray ionization time-of-flight mass spectrometer with electrostatic wire ion guide. Int. J. Mass Spectrom. Ion Processes. 160: 241-258.
56. Edmondson, R. D. and D. H. Russell. 1996. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass measurement accuracy by using delayed extraction. J. Am. Soc. Mass Spectrom. 7: 995-1001.
57. Cruzado, I. D., S. L. Cockrill, C. J. McNeal, and R. D. Macfarlane. 1998. Characterization and quantitation of apolipoprotein B-100 by capillary electrophoresis. J. Lipid Res. 39: 205-217.
58. Mann, M., C. K. Meng, and J. B. Fenn. 1989. Interpreting mass spectra of multiply charged ions. Anal. Chem. 61: 1702-1708.
59. Smith, R. D., J. A. Loo, C. G. Edmonds, C. J. Barinaga, and H. R. Udseth. 1990. New development in biochemical mass spectrometry: electrospray ionisation. Anal. Chem. 62: 882-899.
60. Loo, J. A., H. R. Udseth, and R. D. Smith. 1989. Peptide and protein analysis by electrospray ionization-mass spectrometry and capillary electrophoresis-mass spectrometry. Anal. Biochem. 179: 404-412.
61. Smith, R. D., J. A. Loo, R. R. Ogorzalek Loo, M. Busman, and H. R. Udseth. 1991. Principles and practice of electrospray ionization-mass spectrometry for large polypeptide and proteins. Mass Spectrom. Rev. 10: 359-451.
62. Gotto, A. M., Jr., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128: 3-41.
63. Menzel, H. J., J. P. Kane, M. J. Malloy, and R. J. Havel. 1986. A variant primary structure of apolipoprotein C-II in individuals of African descent. J. Clin. Invest. 77: 595-601.
64. Sepehrnia, B., M. I. Kamboh, and R. E. Ferrell. 1988. Genetic studies of human apolipoproteins. III. Polymorphism of apolipoprotein C-II. Hum. Hered. 38: 136-143.
65. Sepehrnia, B., M. I. Kamboh, L. L. Adams-Campbell, C. H. Bunker, M. Nwankwo, P. P. Majumder, and R. E. Ferrell. 1989. Genetic studies of human apolipoproteins. XI. The effect of the apolipoprotein C-II polymorphism on lipoprotein level in Nigerian blacks. J. Lipid Res. 39: 1349-1355.
66. Pullinger, C. R., B. R. Zysow, L. K. Hennessy, P. H. Frost, M. J. Malloy, and J. P. Kane. 1993. Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia. Hum. Mol. Genet. 2: 69-74.
67. Gotoh, H., M. Hagihara, T. Nagatsu, H. Iwata, and T. Miura. 1988. Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients. Clin. Chem. 34: 2499-2501.
68. Vanhoof, G., F. Goossens, I. De Meester, D. Hendriks, and S. Scharpe. 1995. Proline motifs in peptides and their biological processing. FASEB J. 9: 736-744.
69. Bury, J., W. DeKeersgieter, M. Rosseneu, F. Belpaire, and J. Christophe. 1985. Immunonephelometric quantitation of the apolipoprotein C-III in human plasma. Clin. Chim. Acta. 145: 249-258.
70. von Eckardstein, A., H. Funke, M. Walter, K. Altland, A. Benninghoven, and G. Assmann. 1990. Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265: 8610-8617.
71. Fojo, S. S., A. F. Stalenhoef, K. Marr, R. E. Gregg, R. S. Ross, and H. B. Brewer, Jr. 1988. A deletion mutation in the apoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II. J. Biol. Chem. 263: 17913-17916.
72. Padova kindred. Eur. J. Clin. Invest. 23: 522-528.
73. Padova gene in a patient with apolipoprotein C-II deficiency. J. Clin. Invest. 84: 1213-1219.
74. Paris2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome. J. Lipid Res. 33: 361-367.
75. Bari). Biochem. Biophys. Res. Commun. 168: 1118-1127.
76. Hamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur. J. Clin. Invest. 22: 88-95.
77. Paris) of a patient with a deficiency of apolipoprotein C-II. J. Biol. Chem. 264: 20839-20842.
78. Toronto, a nonfunctional human apolipoprotein. Proc. Natl. Acad. Sci. USA. 84: 270-273.
79. Connelly, P. W., G. F. Maguire, C. Vezina, R. A. Hegele, and J. A. Little. 1993. Identification of disulfide-linked apolipoprotein species in human lipoproteins. J. Lipid Res. 34: 1717-1727.
80. St. Michael: familial apolipoprotein C-II deficiency associated with premature vascular disease. J. Clin. Invest. 80: 1597-1605.
81. Zysow, B. R., C. R. Pullinger, L. K. Hennessy, R. V. J. Farese, M. Ghassemzadeh, and J. P. Kane. 1994. The apolipoprotein C-II variant apo C-II(Lys19→Thr) is not associated with dyslipidemia in an affected kindred. Clin. Genet. 45: 292-297.
82. 45), in a Turkish patient. J. Lipid Res. 35: 1431-1440.
83. Maeda, H., R. K. Hashimoto, T. Ogura, S. Hiraga, and H. Uzawa. 1987. Molecular cloning of a human apoC-III variant: Thr74→ Ala74 mutation prevents O-glycosylation. J. Lipid Res. 28: 1405-1409.
84. von Eckardstein, A., H. Holz, M. Sandkamp, W. Weng, H. Funke, and G. Assmann. 1991. Apolipoprotein C-III(Lys58→Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J. Clin. Invest. 87: 1724-1731.
85. Ferrell, R. E., M. I. Kamboh, P. P. Majumder, R. Valdez, and K. M. Weiss. 1990. Genetic studies of human apolipoproteins. XIII. Quantitative polymorphism of apolipoprotein C-III in the Mayans of the Yucatan peninsula. Hum. Hered. 40: 127-135.
86. Menzel, H. J., R. G. Kladetzky, and G. Assmann. 1983. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 3: 310-315.
87. Lundqvist, M., P. Baltzer, D. Edvardsson, L. Karlsson, and B. Wannberg. 1995. Novel time-of-flight instrument for doppler free kinetic energy release spectroscopy. Phys. Rev. Lett. 75: 1058-1061.
88. Anderson, N. L., R. P. Tracy, and N. G. Anderson. 1984. High-resolution two-dimensional electrophoretic mapping of plasma proteins. In The Plasma Proteins. Structure, Function, and Genetic Control. F.W. Putman, editor. Academic Press, Inc. London. 222-270.